| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
MEDIC Stock Overview
Medicon Hellas S.A. operates in the diagnostics industry.
Medicon Hellas Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.16 |
| 52 Week High | €5.40 |
| 52 Week Low | €2.22 |
| Beta | 0.97 |
| 1 Month Change | 14.08% |
| 3 Month Change | -11.49% |
| 1 Year Change | 29.51% |
| 3 Year Change | 68.09% |
| 5 Year Change | 530.74% |
| Change since IPO | -59.58% |
Recent News & Updates
Medicon Hellas (ATH:MEDIC) May Have Issues Allocating Its Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
Estimating The Intrinsic Value Of Medicon Hellas S.A. (ATH:MEDIC)
In this article we are going to estimate the intrinsic value of Medicon Hellas S.A. ( ATH:MEDIC ) by taking the...
Shareholder Returns
| MEDIC | GR Medical Equipment | GR Market | |
|---|---|---|---|
| 7D | 0.3% | -0.5% | -1.2% |
| 1Y | 29.5% | -23.6% | -1.1% |
Return vs Industry: MEDIC exceeded the Greek Medical Equipment industry which returned -22.6% over the past year.
Return vs Market: MEDIC exceeded the Greek Market which returned -0.5% over the past year.
Price Volatility
| MEDIC volatility | |
|---|---|
| MEDIC Average Weekly Movement | 10.5% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GR Market | 7.2% |
| 10% least volatile stocks in GR Market | 2.9% |
Stable Share Price: MEDIC is more volatile than 90% of Greek stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: MEDIC's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Greek stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 169 | Maria Dimotsantou Sotiriou | https://www.mediconsa.com |
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company imports and distributes analytical workstations for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems under the MLR name.
Medicon Hellas Fundamentals Summary
| MEDIC fundamental statistics | |
|---|---|
| Market Cap | €13.97m |
| Earnings (TTM) | €3.04m |
| Revenue (TTM) | €21.51m |
4.6x
P/E Ratio0.6x
P/S RatioIs MEDIC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDIC income statement (TTM) | |
|---|---|
| Revenue | €21.51m |
| Cost of Revenue | €5.82m |
| Gross Profit | €15.69m |
| Other Expenses | €12.65m |
| Earnings | €3.04m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.69 |
| Gross Margin | 72.94% |
| Net Profit Margin | 14.14% |
| Debt/Equity Ratio | 75.9% |
How did MEDIC perform over the long term?
See historical performance and comparisonValuation
Is MEDIC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MEDIC?
Other financial metrics that can be useful for relative valuation.
| What is MEDIC's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | €13.97m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.8x |
| Enterprise Value/EBITDA | 2.7x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does MEDIC's PE Ratio compare to its peers?
| MEDIC PE Ratio vs Peers |
|---|
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 26.4x | ||
VIDAVO Vidavo | 57.3x | n/a | €3.4m |
ALEMG Euromedis Groupe | 7.4x | 17.6% | €16.7m |
RAYT Rayont | 38.4x | n/a | US$14.4m |
VASO Vaso | 2.5x | n/a | US$16.3m |
MEDIC Medicon Hellas | 4.6x | n/a | €14.0m |
Price-To-Earnings vs Peers: MEDIC is good value based on its Price-To-Earnings Ratio (4.6x) compared to the peer average (26.4x).
Price to Earnings Ratio vs Industry
How does MEDIC's PE Ratio compare vs other companies in the European Medical Equipment Industry?
Price-To-Earnings vs Industry: MEDIC is good value based on its Price-To-Earnings Ratio (4.6x) compared to the European Medical Equipment industry average (28.2x)
Price to Earnings Ratio vs Fair Ratio
What is MEDIC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 4.6x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MEDIC's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of MEDIC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MEDIC (€3.16) is trading below our estimate of fair value (€16.36)
Significantly Below Fair Value: MEDIC is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Future Growth
How is Medicon Hellas forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
16.0%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medicon Hellas has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine whether Medicon Hellas is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Medicon Hellas competitive advantages and company strategy can generally be found in its financial reports archived here.
Past Performance
How has Medicon Hellas performed over the past 5 years?
Past Performance Score
6/6Past Performance Score 6/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
4.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MEDIC has high quality earnings.
Growing Profit Margin: MEDIC's current net profit margins (14.1%) are higher than last year (5%).
Past Earnings Growth Analysis
Earnings Trend: MEDIC's earnings have grown by 4.2% per year over the past 5 years.
Accelerating Growth: MEDIC's earnings growth over the past year (301.8%) exceeds its 5-year average (4.2% per year).
Earnings vs Industry: MEDIC earnings growth over the past year (301.8%) exceeded the Medical Equipment industry 23.1%.
Return on Equity
High ROE: MEDIC's Return on Equity (21.7%) is considered high.
Discover strong past performing companies
Financial Health
How is Medicon Hellas's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: MEDIC's short term assets (€21.1M) exceed its short term liabilities (€4.7M).
Long Term Liabilities: MEDIC's short term assets (€21.1M) exceed its long term liabilities (€11.5M).
Debt to Equity History and Analysis
Debt Level: MEDIC's net debt to equity ratio (6.5%) is considered satisfactory.
Reducing Debt: MEDIC's debt to equity ratio has reduced from 350% to 75.9% over the past 5 years.
Debt Coverage: MEDIC's debt is well covered by operating cash flow (42.3%).
Interest Coverage: MEDIC's interest payments on its debt are well covered by EBIT (34x coverage).
Balance Sheet
Discover healthy companies
Dividend
What is Medicon Hellas's current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MEDIC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MEDIC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MEDIC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MEDIC's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: MEDIC is not paying a notable dividend for the Greek market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as MEDIC has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
8.4yrs
Average board tenure
CEO
Maria Dimotsantou Sotiriou (69 yo)
no data
Tenure
Ms. Maria Dimotsantou Sotiriou has been the Chairman of the Board and Chief Executive Officer of Medicon Hellas S.A. since October 31, 2014. Ms. Dimotsantou Sotiriou speaks English.
Board Members
Experienced Board: MEDIC's board of directors are considered experienced (8.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Medicon Hellas S.A.'s employee growth, exchange listings and data sources
Key Information
- Name: Medicon Hellas S.A.
- Ticker: MEDIC
- Exchange: ATSE
- Founded: 1988
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: €13.966m
- Shares outstanding: 4.42m
- Website: https://www.mediconsa.com
Number of Employees
Location
- Medicon Hellas S.A.
- Melitona 5-7
- Gerakas
- 153 44
- Greece
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/08/09 00:00 |
| End of Day Share Price | 2022/08/09 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.